Products

First Relief®

The First Relief® percutaneous electrical nerve field stimulator (PENS) is designed to administer auricular neurostimulation treatment over 168 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area.

First Relief® neurostimulation therapy has been cleared by the FDA to treat neuropathic pain in Type II diabetics. First Relief® therapy allows

neurostimulation over a period over 16 weeks using 8 treatments while offering the patient a high degree of comfort and mobility. First Relief® neurostimulation therapy has been cleared by the FDA to treat neuropathic pain in Type II diabetics. First Relief® therapy allows neurostimulation over a period over 16 weeks using 8 treatments while offering the patient a high degree of comfort and mobility.

First Relief v1 therapy has been cleared by the FDA to reduce functional abdominal pain in patients with irritable bowel syndrome First Relief v1 therapy allows neurostimulation over 3 weeks using 3 treatments while offering the patient a high degree of comfort and mobility.

Use of the First Relief® therapy allows for a minimized use of opioid agonist treatment and in some cases may eliminate it.

First Relief® devices come packaged 10 to a box.

Drug Relief®

The DrugRelief® percutaneous electrical nerve field stimulator (PNFS) is designed to administer auricular neurostimulation treatment over 120 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area. DrugRelief® neurostimulation therapy is used mainly to reduce the symptoms of drug withdrawal during detoxification.

Drug Relief® therapy allows continuous neurostimulation over a period of 5 days while offering the patient a high degree of comfort and mobility. Use of the Drug Relief® therapy allows for a minimized use of opioid agonist treatment and in some cases may eliminate it.

DrugRelief® devices come packaged 5 to a box.

Primary Relief®

The Primary Relief® percutaneous electrical nerve field stimulator (PENS) is designed to administer auricular neurostimulation treatment over 72 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area.

Primary Relief® neurostimulation therapy is used mainly to manage post surgical pain.

It has been cleared by the FDA, initially, for post Cesarean section pain and cardiac surgery. Primary Relief® therapy allows neurostimulation over a period over 3 days while offering the patient a high degree of comfort and mobility. Use of the Primary Relief® therapy allows for a minimized use of opioid agonist treatment and in some cases may eliminate it.

Primary Relief® devices come packaged 10 to a box.

Products

First Relief

Drug Relief

Primary Relief

First Relief®

Drug Relief®

Primary Relief®

Quick Links

Explore

Get In Touch